Cite

    Sun, X. et al. (2020). Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study. Lancet oncology. 21 (9), pp. 1173-1187. [Online].